Metabolic Bariatric Surgery for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Scoping Review of Biomarker and Histology Changes

被引：0
|
作者：
Shah, A. [1 ]
Mohammadi, A. [3 ]
Haq, A. [4 ]
Walji, D. [5 ]
Zevin, B. [2 ]
机构：
[1] Queens Univ, Med, Kingston, ON, Canada
[2] Queens Univ, Dept Surg, Kingston, ON, Canada
[3] Toronto Metropolitan Univ, Toronto, ON, Canada
[4] Queens Univ, Kingston, ON, Canada
[5] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2025年 / 73卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
251
引用
收藏
页码：297 / 299
页数：3
相关论文
共 50 条
  • [1] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Do, Albert
    Zahrawi, Frhaan
    Mehal, Wajahat Z.
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (03) : 171 - 189
  • [2] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Do, Albert
    Zahrawi, Frhaan
    Mehal, Wajahat Z.
    NATURE REVIEWS DRUG DISCOVERY, 2024,
  • [3] Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
    Albert Do
    Frhaan Zahrawi
    Wajahat Z. Mehal
    Nature Reviews Drug Discovery, 2025, 24 (3) : 171 - 189
  • [4] Evaluating the Impact of Cenicriviroc in Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Systematic Review
    Singh, Avneet
    Garcia, Alexander
    Hasan, Fariha
    Laique, Fatima
    Mohiuddin, Mubashir
    Haris, Muhammad
    Abidi, Zehara
    Jover, Queenzy
    Awadallah, Mina
    Wakil, Ali
    Nguyen, Tommy
    Roy, Satyajeet
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1249 - S1250
  • [5] Silent MASH: A Case of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Normal Aminotransferases
    Li, Elizabeth
    Vallabhaneni, Manasa
    Lin, Joanne
    Hogan, Carolyn
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2778 - S2778
  • [6] Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists
    Mauricio, Didac
    Escalada, Javier
    Perez, Antonio
    Romero-Gomez, Manuel
    Cusi, Kenneth
    Younoussi, Zobair M.
    Lazarus, Jeffrey V.
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2024, 71 (04): : 149 - 151
  • [7] Metabolic issues in patients with metabolic dysfunction-associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review
    Alnimer, Lynna
    Arellano, Diego
    Brombosz, Elizabeth
    Noureddin, Mazen
    LIVER TRANSPLANTATION, 2024,
  • [8] Found in translation-Fibrosis in metabolic dysfunction-associated steatohepatitis (MASH)
    Wang, Shuang
    Friedman, Scott L.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (716)
  • [9] Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis
    Li, Xincheng
    Ayada, Ibrahim
    Li, Pengfei
    Pan, Qiuwei
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (02): : 108 - 109
  • [10] THERAPEUTIC HORIZONS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE( MASLD) & METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS( MASH): A SYSTEMATIC REVIEW OF CURRENT TREATMENT OPTION
    Moliya, Pratiksha
    Al-Obaidi, Hasan
    Patel, Pranav
    Patel, Raj
    Parikh, Charmy
    Joy, Melvin
    HEPATOLOGY, 2024, 80
12345